Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
419.2 INR | -2.02% | -4.40% | -2.53% |
05-30 | Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab | MT |
05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.53% | 2.77B | |
+39.82% | 734B | |
+31.46% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+13.66% | 238B | |
-6.58% | 204B | |
+8.11% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Transcript : Laurus Labs Limited, Q4 2023 Earnings Call, Apr 27, 2023